 |
市場調査レポート
商品コード
1322078
IVD品質管理の世界市場 (2023-2030年)：製品&サービス・用途・製造業者タイプ別の規模・シェア・成長分析・予測Global IVD Quality Control Market Size, Share, Growth Analysis, By Product and Service, By Application, By Manufacturer type - Industry Forecast 2023-2030 |
||||||
| IVD品質管理の世界市場 (2023-2030年)：製品&サービス・用途・製造業者タイプ別の規模・シェア・成長分析・予測 |
|
出版日: 2023年07月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
IVD品質管理の市場規模は、2021年の10億2,000万米ドル、2022年の10億6,000万米ドルから、予測期間中は4.1%のCAGRで推移し、2030年には14億6,000万米ドルの規模に成長すると予測されています。
臨床ラボ、高齢化、外部の品質評価プログラムへのニーズの高まり、新興国市場でのPOC機器使用の拡大、第三者による品質管理の増加などの要因が世界のIVD品質管理市場の成長に寄与しています。感染症、HIV、癌の世界的な増加により、効率的な治療とその効果を追跡するための品質管理のための新しい診断法が求められています。国連エイズ合同計画によると、2019年に抗レトロウイルス療法を受けたHIV患者は推定2,450万人です。迅速な診断システムと質の高い進化支援へのニーズの高まりにより、市場は拡大しています。
数多くの疾病の流行が増加しており、臨床検査の数が増加しています。2019年12月のCOVID-19の急拡大により、診断検査に対する大きなニーズが生まれ、臨床検査の能力拡大のために、多くの政府機関が多くの研究所を設立しました。これらのことも市場の拡大を促進しています。
医療機器企業は、各種疾病の増加により、最先端技術を用いた診断ツールの開発に注力しています。正確なリアルタイムデータを得るためにポイントオブケア検査機器が病院やラボでますます好まれるようになっており、これらの機器の需要が急増し、市場の拡大を後押ししています。
当レポートでは、世界のIVD品質管理の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
世界のIVD品質管理市場：製品・サービス別
- 市場概要
- 品質管理製品
- データ管理ソリューション
- 品質保証サービス
世界のIVD品質管理市場：用途別
- 市場概要
- 臨床化学
- 免疫化学/免疫測定
- 血液
- 分子診断
- 凝固・止血
- 微生物
- その他
世界のIVD品質管理市場：製造業者タイプ別
- 市場概要
- サードパーティ制御製造業者
- OEM
世界のIVD品質管理市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
主要企業プロファイル
- Bio-Rad Laboratories
- Abbott Laboratories
- Siemens Healthineers
- Thermo Fisher Scientific
- Roche Diagnostics
- Randox Laboratories
- Bio-Techne Corporation
- Or
IVD Quality Control Market size was valued at USD 1.02 billion in 2021 and is poised to grow from USD 1.06 billion in 2022 to USD 1.46 billion by 2030, growing at a CAGR of 4.1% in the forecast period (2023-2030).
Clinical laboratories, an aging population, rising need for external quality assessment programs, expanding POC instrument use in developed nations, and an increase in third-party quality control are all factors contributing to the growth of the worldwide IVD quality control market. Increased prevalence of infectious diseases, HIV, and cancers worldwide, which call for novel diagnostics for efficient treatment and quality control to track their effectiveness. An estimated 24.5 million HIV patients received antiretroviral therapy in 2019, according to the Joint United Nations Program on HIV and AIDS. The market is expanding as a result of quick diagnosis systems and increased need for high-quality evolution assistance.
Top-down and bottom-up approaches were used to estimate and validate the size of IVD Quality Control and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
The market for quality control of in vitro diagnostics (IVD) is divided into product and service, application, manufacturer type, end user, and geography. The IVD Quality Control Market is divided into quality control products, data management solutions, and quality assurance services based on the service and product offered. Clinical chemistry, immunochemistry/immunoassay, hematology, molecular diagnostics, coagulation and hemostasis, microbiology, and others are the different application categories that make up the global market. The global IVD Quality Control Market is segmented into original equipment manufacturers and third-party control manufacturers based on the type of manufacturer. Hospitals, home care settings, clinical laboratories, and academic and research institutes are the different end user segments of the worldwide IVD Quality Control Market.
Driver
Increasing Authorized Clinical Laboratory Across the Globe
The prevalence of numerous diseases is rising, which raises the number of laboratory tests. so that the number of laboratories in the public and private sectors will expand. The rapid growth of COVID-19 in December 2019 created a significant need for diagnostic tests. To expand the capability of laboratory testing, numerous government agencies have set up more laboratories. Consequently, fuel market expansion.
Restraints
Additional Cost and Budget Constraints in Hospital and Laboratories
Investment and experience are required in a hospital to build up a QC procedure. Adoption of QC processes is expensive in clinical laboratories using low volume QC procedures. This reduces the adoption of QC techniques together with budgetary restrictions in many hospitals and laboratories.
Market Trend
Medical device businesses are continually concentrating on the creation of technologically cutting-edge diagnostic tools due to the rising occurrence of diseases. Point-of-care testing devices are increasingly preferred by hospitals and laboratories in order to obtain precise real-time data. As a result, there is a surge in demand for point-of-care testing equipment, which fuels the market's expansion.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global IVD Quality Control Market by Product and Service
- Market Overview
- Quality control products
- data management solutions
- and quality assurance services.
Global IVD Quality Control Market by Application
- Market Overview
- Clinical Chemistry
- immunochemistry/immunoassay
- hematology
- molecular diagnostics
- coagulation and hemostasis
- microbiology
- and others
Global IVD Quality Control Market by Manufacturer type
- Market Overview
- Third-party control manufacturers
- and original equipment manufacturers
Global IVD Quality Control Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Or
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
